A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
Adoptive immunotherapy using TCR gene-modified T-lymphocytes is an attractive strategy for targeting malignancies. However, TCR mispairings between endogenous and introduced TCR chains are a major concern, as they may induce mixed TCRs with unknown specificities and may reduce the expression of ther...
Saved in:
Main Authors: | Sachiko Okamoto (Author), Yasunori Amaishi (Author), Yumi Goto (Author), Hiroaki Ikeda (Author), Hiroshi Fujiwara (Author), Kiyotaka Kuzushima (Author), Masaki Yasukawa (Author), Hiroshi Shiku (Author), Junichi Mineno (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2012-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
TCR Coexpression Signature Predicts Immunotherapy Resistance in NSCLC
by: Yuntao Wang, et al.
Published: (2022) -
Circulating TCR γδ Cells in the Patients with Systemic Lupus Erythematosus
by: Ewa Robak, et al.
Published: (1999) -
Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
by: Zhi Pang, et al.
Published: (2023) -
The potential applications of T cell receptor (TCR)-like antibody in cervical cancer immunotherapy
by: Sylvia Annabel Dass, et al.
Published: (2021) -
CAR-J cells for antibody discovery and lead optimization of TCR-like immunoglobulins
by: Christian Jost, et al.
Published: (2020)